Nort sur Erdre, France

Pascal Marchand


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pascal Marchand

Introduction

Pascal Marchand is a notable inventor based in Nort sur Erdre, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His work focuses on addressing critical health issues related to cellular signal transduction processes.

Latest Patents

Marchand holds a patent for "Naphthyridine derivatives and the use thereof as kinase inhibitors." This invention relates to kinase modulators of the naphthyridine type and their application as medicaments. These compounds are designed to modulate misdirected cellular signal transduction processes, which can influence the function of tyrosine and serine/threonine kinases. The patent aims to provide treatment options for malignant or benign tumors and other disorders associated with pathological cell proliferation, such as restenosis, psoriasis, arteriosclerosis, and cirrhosis of the liver. He has 1 patent to his name.

Career Highlights

Pascal Marchand is currently associated with Aeterna Zentaris GmbH, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry.

Collaborations

Marchand has collaborated with notable colleagues, including Tilmann Schuster and Matthias Gerlach. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Pascal Marchand's contributions to the field of medicinal chemistry and his innovative patent for kinase inhibitors highlight his commitment to addressing significant health challenges. His work continues to inspire advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…